Cystic Fibrosis, 10011762 research hub

A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF

This study is testing a medicine called anakinra for people aged 12 and over with cystic fibrosis (CF). Researchers want to see if it helps improve lung health and is safe to use. It's an early-stage study to understand its effects better.